Molecularly, IDH1/2 mutations are a hallmark, with oligodendrogliomas defined by 1p/19q codeletion and astrocytomas often harboring ATRX and TP53 mutations (1). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).